Form 8-K - Current report:
SEC Accession No. 0000950170-25-001159
Filing Date
2025-01-03
Accepted
2025-01-03 16:10:07
Documents
11
Period of Report
2025-01-02
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K bolt-20250102.htm   iXBRL 8-K 41258
  Complete submission text file 0000950170-25-001159.txt   159108

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bolt-20250102.xsd EX-101.SCH 25969
13 EXTRACTED XBRL INSTANCE DOCUMENT bolt-20250102_htm.xml XML 4940
Mailing Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-665-9295
Bolt Biotherapeutics, Inc. (Filer) CIK: 0001641281 (see all company filings)

IRS No.: 472804636 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39988 | Film No.: 25506161
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)